Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1979 1
1987 1
1989 2
1995 1
1996 1
1997 1
2004 2
2005 6
2006 5
2008 1
2010 2
2012 2
2013 4
2014 2
2015 4
2016 4
2017 2
2018 5
2019 2
2020 3
2021 2
2022 2
2023 2
2024 6
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

56 results

Results by year

Filters applied: . Clear all
Page 1
Assessing the efficacy and tolerability of PET-guided BrECADD versus eBEACOPP in advanced-stage, classical Hodgkin lymphoma (HD21): a randomised, multicentre, parallel, open-label, phase 3 trial.
Borchmann P, Ferdinandus J, Schneider G, Moccia A, Greil R, Hertzberg M, Schaub V, Hüttmann A, Keil F, Dierlamm J, Hänel M, Novak U, Meissner J, Zimmermann A, Mathas S, Zijlstra JM, Fosså A, Viardot A, Hertenstein B, Martin S, Giri P, Scholl S, Topp MS, Jung W, Vucinic V, Beck HJ, Kerkhoff A, Unger B, Rank A, Schroers R, Zum Büschenfelde CM, de Wit M, Trautmann-Grill K, Kamper P, Molin D, Kreissl S, Kaul H, von Tresckow B, Borchmann S, Behringer K, Fuchs M, Rosenwald A, Klapper W, Eich HT, Baues C, Zomas A, Hallek M, Dietlein M, Kobe C, Diehl V; German Hodgkin Study Group; Swiss Group for Clinical Cancer Research; Arbeitsgemeinschaft Medikamentöse Tumortherapie; Nordic Lymphoma Group; Australasian Leukaemia and Lymphoma Group. Borchmann P, et al. Among authors: behringer k. Lancet. 2024 Jul 27;404(10450):341-352. doi: 10.1016/S0140-6736(24)01315-1. Epub 2024 Jul 3. Lancet. 2024. PMID: 38971175 Free article. Clinical Trial.
Incorporation of brentuximab vedotin into first-line treatment of advanced classical Hodgkin's lymphoma: final analysis of a phase 2 randomised trial by the German Hodgkin Study Group.
Eichenauer DA, Plütschow A, Kreissl S, Sökler M, Hellmuth JC, Meissner J, Mathas S, Topp MS, Behringer K, Klapper W, Kuhnert G, Dietlein M, Kobe C, Fuchs M, Diehl V, Engert A, Borchmann P. Eichenauer DA, et al. Among authors: behringer k. Lancet Oncol. 2017 Dec;18(12):1680-1687. doi: 10.1016/S1470-2045(17)30696-4. Epub 2017 Nov 10. Lancet Oncol. 2017. PMID: 29133014 Clinical Trial.
Impact of individualized treatment on recovery from fatigue and return to work in survivors of advanced-stage Hodgkin's lymphoma: results from the randomized international GHSG HD18 trial.
Ferdinandus J, Müller H, Damaschin C, Jacob AS, Meissner J, Krasniqi F, Mey U, Schöndube D, Thiemer J, Mathas S, Zijlstra J, Greil R, Feuring-Buske M, Markova J, Rüffer JU, Kobe C, Eich HT, Baues C, Fuchs M, Borchmann P, Behringer K. Ferdinandus J, et al. Among authors: behringer k. Ann Oncol. 2024 Mar;35(3):276-284. doi: 10.1016/j.annonc.2023.11.014. Epub 2023 Dec 5. Ann Oncol. 2024. PMID: 38061428 Free article.
Clinician Distress with Treatments at the Frontier of Mortality.
Callahan KP, Taha D, Dewitt A, Munson DA, Behringer K, Feudtner C. Callahan KP, et al. Among authors: behringer k. J Pediatr. 2023 Jan;252:183-187. doi: 10.1016/j.jpeds.2022.09.013. Epub 2022 Sep 15. J Pediatr. 2023. PMID: 36115624 Free PMC article. No abstract available.
Patient-reported outcomes in Hodgkin lymphoma trials: a systematic review.
Oliva EN, Ionova T, Laane E, Csenar M, Schroer J, Behringer K, Monsef I, Oeser A, Skoetz N, Salek S. Oliva EN, et al. Among authors: behringer k. Front Oncol. 2024 Mar 13;14:1353101. doi: 10.3389/fonc.2024.1353101. eCollection 2024. Front Oncol. 2024. PMID: 38544841 Free PMC article.
[Modern pharmacotherapy of Hodgkin disease].
Josting A, Behringer K, Engert A, Diehl V. Josting A, et al. Among authors: behringer k. Internist (Berl). 2004 Jan;45(1):93-101. doi: 10.1007/s00108-003-1094-2. Internist (Berl). 2004. PMID: 14735247 Review. German.
Lelliottia aquatilis sp. nov., isolated from drinking water.
Kämpfer P, Glaeser SP, Packroff G, Behringer K, Exner M, Chakraborty T, Schmithausen RM, Doijad S. Kämpfer P, et al. Among authors: behringer k. Int J Syst Evol Microbiol. 2018 Aug;68(8):2454-2461. doi: 10.1099/ijsem.0.002854. Epub 2018 Jun 22. Int J Syst Evol Microbiol. 2018. PMID: 29932385
56 results